Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Quick Stats
Jan 30, 202658.0
AI Score
HOLD2.81
Volume Ratio
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
KPRX Stock Summary
Last updated Jan 30, 2026
KPRX is currently trading at $2.4, positioned below its 200-day moving average of $2.63, suggesting bearish momentum. The stock has a 52-week range of $1.7645 to $4.18.
Technical Analysis: The 50-day moving average stands at $2.07, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.071, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.462, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates KPRX at 58.0/100 with a HOLD recommendation.
KPRX (Kiora Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.071 |
| CMF (20) | 0.462 |
| ROC (10) | 9.589 |
| ADX (14) | 13.338 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.038 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -2.564 |
| MFI (14) | 73.162 |
KPRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KPRX Price vs Max Options Open Interest
KPRX Max Change In Options Open Interest
KPRX Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPRX Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPRX Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPRX Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Kiora Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KPRX Moving Averages Analysis
Kiora Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
KPRX (Kiora Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.19 |
| 20 | 2.17 |
| 30 | 2.13 |
| 50 | 2.07 |
| 100 | 2.31 |
| 200 | 2.63 |
KPRX Fundamental Analysis
| P/E (Forward) | 2.4102 |
| P/E (Trailing) | -- |
| Market Cap ($) | 8.5 million |
| Earnings/Share ($) | -2.19 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.39 |
| EPS Estimate Next Year ($) | -2.23 |
| WallStreet Target Price ($) | 12 |
| Most Recent Quarter |